|Articles|April 23, 2018
CRF Health’s TrialMax eCOA Solution Selected for Landmark Pain Outcomes Study
Advertisement
CRF Health announced that its TrialMax Touch and TrialMax Slate solutions have been selected by a Global Category Japanese Pharmaceutical company for a pain outcomes study. The Phase III trial will involve 800 screened and 320 randomized subjects across 40 sites in the US.
Read the full release
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: Selective Safety Data and Visit Reduction, Protocol Design Execution Gaps, and China Trial Security Investigation
2
ACT Brief: Tavneos Trial Integrity Issues, Selective Safety Data Regulatory Pathways, and FDA PreCheck Program Launch
3
Protocol Design Doesn't Fail in the Protocol, It Fails in Transition to Trial
4
The Data Behind Reducing Trial Burden Without Sacrificing Quality
5